Tariff Tsunami: Drugmakers' U.S. Manufacturing Blitz
Update: 2025-10-01
Description
October 1st Tariff Deadline Sparks Pharmaceutical Frenzy: Major drugmakers like Pfizer and GSK are scrambling to invest billions in U.S. manufacturing to dodge a looming 100% tariff on imported drugs. Discover how this massive shift is creating jobs, reshaping supply chains, and what it means for the future of drug prices in America. Will it protect consumers or trigger price spikes?
Hosted on Acast. See acast.com/privacy for more information.
Comments
In Channel
Download from Google Play
Download from App Store
United States00:00
00:00
1.0x
